Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. [electronic resource]

By: Contributor(s): Producer: 20091104Description: 1247; author reply 1247-8 p. digitalISSN:
  • 1526-632X
Subject(s): Online resources: In: Neurology vol. 73
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Comment; Letter

There are no comments on this title.

to post a comment.